Breakthrough Enzyme Discovery Could Enhance Ozempic’s Weight Loss Effects

If you’ve walked past the pharmacy counter at your local Austin H-E-B lately, you’ve probably noticed the same thing: empty shelves where Ozempic and Wegovy used to be. The GLP-1 revolution has reshaped weight-loss conversations from the Domain food trucks to the jogging trails around Lady Bird Lake, but for many Central Texans, the side effects—nausea, muscle loss, the dreaded “Ozempic face”—have turned what should be a medical breakthrough into a daily gamble. Now, a discovery from Stanford Medicine is sending ripples through the Hill Country’s diabetes and obesity research community, offering a glimpse of a future where the promise of these drugs might finally align with the reality of living in a city where 32% of adults are classified as obese and Type 2 diabetes rates have climbed 18% in the last decade.

On April 12, 2026, Stanford scientists announced the identification of a naturally occurring peptide called BRP (brain-regulating peptide) that appears to mimic the appetite-suppressing effects of semaglutide—the active ingredient in Ozempic—without many of its most troubling side effects. Unlike Ozempic, which targets GLP-1 receptors scattered throughout the gut, pancreas, and brain, BRP appears to act specifically on the hypothalamus, the brain’s appetite-control center. In animal studies, it reduced food intake and body weight while avoiding nausea, constipation, and muscle loss—three of the most common complaints among Austinites who’ve tried GLP-1 drugs.

“The receptors targeted by semaglutide are found in the brain but too in the gut, pancreas, and other tissues,” said Katrin Svensson, PhD, assistant professor of pathology at Stanford Medicine. “That’s why Ozempic has such widespread effects, including slowing the movement of food through the digestive tract and lowering blood sugar levels. In contrast, BRP appears to act specifically in the hypothalamus, which controls appetite and metabolism.” For a city like Austin, where the intersection of tech-driven sedentary lifestyles and a food culture built around breakfast tacos and barbecue has created a perfect storm for metabolic disease, the implications are profound. Could BRP offer a way to curb obesity without the trade-offs that have left so many Central Texans cycling on and off these drugs?

The Genetic Wild Card: Why Ozempic Doesn’t Perform for Everyone

But here’s the catch: even if BRP lives up to its early promise, it won’t be a silver bullet. A separate study from Stanford, published just days before the BRP announcement, revealed that about 10% of the population carries genetic variants linked to a newly identified phenomenon called “GLP-1 resistance.” In these individuals, levels of the hormone GLP-1 are actually higher than normal, but their bodies don’t respond to it properly—meaning drugs like Ozempic and Wegovy may be less effective, or even ineffective, for them.

This discovery sheds light on a frustrating reality for many Austinites: why some people lose dramatic amounts of weight on Ozempic while others see little to no change. “More than one in four people with Type 2 diabetes use GLP-1 receptor agonists,” the study noted, “but new research suggests these drugs may be less effective for some individuals due to genetic differences.” For a city where diabetes prevalence is higher than the national average—and where the tech industry’s wellness programs have made GLP-1 drugs a common (if controversial) employee benefit—the news is a reminder that personalized medicine isn’t just a buzzword. It’s a necessity.

At Dell Medical School, where researchers have been studying the metabolic effects of Austin’s urban design—think heat islands, food deserts in East Austin, and the lack of walkable infrastructure—this genetic insight could reshape how clinicians approach weight loss and diabetes management. “We’ve known for years that obesity and diabetes are complex, multifactorial diseases,” said Dr. Sarah Johnson, a metabolic health researcher at Dell who was not involved in the Stanford study. “But this genetic resistance adds another layer. It’s not just about diet and exercise anymore. It’s about understanding why some people’s bodies respond differently to these drugs—and what One can do about it.”

The Pancreas’s Hidden Trick: A Backup System for Blood Sugar Control

While Stanford’s BRP discovery is making headlines, another piece of the puzzle emerged last fall from Duke University: the pancreas itself may be producing its own version of Ozempic. Researchers found that pancreatic alpha cells, long believed to only produce glucagon (a hormone that raises blood sugar), also generate GLP-1—the same hormone mimicked by semaglutide. Even more surprising, when glucagon production is blocked, these cells “switch gears” and boost GLP-1 output, enhancing insulin release and improving blood sugar control.

“This represents a game-changer,” said Jonathan Campbell, PhD, the Duke scientist who led the study. “It suggests that the pancreas has a built-in backup system for regulating blood sugar, one that we might be able to harness or enhance with future therapies.” For Austin’s growing population of prediabetic and diabetic residents—many of whom are uninsured or underinsured—the implications are significant. If the pancreas can naturally produce GLP-1, could that pave the way for treatments that don’t rely on expensive, injectable drugs? Could it lead to oral medications or even dietary interventions that stimulate the pancreas’s own GLP-1 production?

At the Austin Diagnostic Clinic, endocrinologists are already fielding questions from patients about whether these discoveries could lead to alternatives to Ozempic. “Patients are tired of the side effects, and they’re tired of the cost,” said Dr. Maria Rodriguez, an endocrinologist at the clinic. “If BRP or something like it can deliver the same benefits without the nausea or muscle loss, that’s a huge win. And if we can find a way to activate the pancreas’s natural GLP-1 production, that could be revolutionary.”

What In other words for Austin: Beyond the Hype

For a city that prides itself on being at the forefront of innovation—whether in tech, music, or food—Austin’s health landscape is still playing catch-up when it comes to metabolic disease. The BRP discovery and the genetic insights around GLP-1 resistance aren’t just academic curiosities. They’re potential lifelines for a community where:

• Nearly 1 in 3 adults is obese, according to the Austin Public Health Department.
• Type 2 diabetes rates have risen steadily over the past decade, with some ZIP codes in East Austin seeing rates as high as 15%.
• The average cost of Ozempic in Austin is $1,200 per month without insurance, putting it out of reach for many.

But the path from lab discovery to local pharmacy shelf is long and uncertain. BRP is still in the early stages of animal testing, and even if it proves safe and effective in humans, it could be years before it’s available to the public. In the meantime, Austinites are left navigating a landscape of expensive drugs, genetic lottery tickets, and a healthcare system that’s still catching up to the demand for metabolic health solutions.

So what can you do if you’re one of the thousands of Central Texans struggling with obesity or diabetes? The answer isn’t as simple as “wait for the next miracle drug.” It’s about understanding that metabolic health is a puzzle—and these discoveries are just new pieces that might facilitate complete the picture.

Given My Background in Public Health and Chronic Disease Prevention, Here’s Who Consider Talk to in Austin

If you’re in Austin and this news has you rethinking your approach to weight loss or diabetes management, here are the three types of local professionals who can help you navigate this evolving landscape—along with exactly what to look for when choosing one.

Metabolic Health Specialists (Endocrinologists with a Focus on Obesity Medicine)

What they do: These are board-certified endocrinologists who specialize in the hormonal and metabolic factors contributing to obesity and diabetes. They can help you understand whether GLP-1 drugs like Ozempic are right for you, explore alternatives like BRP (once available), and interpret genetic testing for GLP-1 resistance.

What to look for:

• Board certification in obesity medicine (look for the American Board of Obesity Medicine credential).
• Experience with genetic testing for metabolic conditions (ask if they’ve worked with patients who have GLP-1 resistance).
• Affiliation with a research institution like Dell Medical School or Seton Healthcare Family, where they’re likely to be up-to-date on the latest discoveries.
• Willingness to discuss lifestyle interventions alongside medication (avoid providers who only push drugs).

Where to find them: Start with the Dell Medical School’s endocrinology clinic or the Austin Diabetes and Endocrinology practice.

Functional Medicine Practitioners (MDs or NDs with a Holistic Approach)

What they do: These providers seize a whole-body approach to metabolic health, focusing on diet, gut health, inflammation, and hormonal balance. They can help you explore whether your pancreas’s natural GLP-1 production might be optimized through diet (e.g., high-fiber foods, fermented foods) or supplements (e.g., berberine, which has been shown to increase GLP-1 levels).

What to look for:

• Certification from the Institute for Functional Medicine (IFM) or a similar reputable organization.
• Experience working with metabolic conditions like insulin resistance, prediabetes, and obesity.
• Willingness to run advanced lab tests (e.g., fasting insulin, leptin levels, gut microbiome analysis).
• Transparency about costs (functional medicine is often not covered by insurance).

Where to find them: Check out Austin Functional Medicine or the White Lotus Clinic, both of which have practitioners with IFM certification.

Genetic Counselors Specializing in Metabolic Health

What they do: If you’re curious about whether you might have GLP-1 resistance or other genetic factors affecting your response to weight-loss drugs, a genetic counselor can help you interpret test results and craft informed decisions about treatment. They can also guide you on whether genetic testing (e.g., through companies like 23andMe or Color) might be worthwhile.

What to look for:

• Certification from the American Board of Genetic Counseling (ABGC).
• Experience with metabolic or endocrine genetics (ask if they’ve worked with patients considering GLP-1 drugs).
• Affiliation with a major hospital system (e.g., Ascension Seton) or a reputable genetics lab.
• Ability to explain complex genetic concepts in plain language (avoid providers who overwhelm you with jargon).

Where to find them: The Ascension Seton Genetics Program offers genetic counseling services, as does the Texas Children’s Hospital Genetics Clinic (which also sees adults).

One final note: if you’re considering genetic testing, be wary of direct-to-consumer kits that promise to predict your response to Ozempic or other GLP-1 drugs. The science is still evolving, and many of these tests aren’t yet validated for clinical use. Always consult a genetic counselor or metabolic health specialist before making medical decisions based on genetic data.

Ready to find trusted professionals? Browse our complete directory of top-rated metabolic health experts in the Austin area today.